Clinical Trial Update: A Phase I, Open-label, Study of Pazopanib in Combination With Gemcitabine and Gemcitabine Plus Cisplatin for Advanced Solid Tumors [Phase 1]

View source ↗

Summary

A Phase I, open-label study evaluating pazopanib in combination with gemcitabine, with or without cisplatin, in patients with advanced solid tumors including no…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Non-small Cell Lung Cancer

Drugs mentioned

• Gemzar (gemcitabine)
• Pazopanib (Pazopanib)
• Platinol (cisplatin)

Snippet

Sponsor: GlaxoSmithKline | Conditions: Lung Cancer, Non-Small Cell | Phase 1 | Status: COMPLETED